JPH0228192A - Novel oligosaccaride and production thereof - Google Patents

Novel oligosaccaride and production thereof

Info

Publication number
JPH0228192A
JPH0228192A JP6005388A JP6005388A JPH0228192A JP H0228192 A JPH0228192 A JP H0228192A JP 6005388 A JP6005388 A JP 6005388A JP 6005388 A JP6005388 A JP 6005388A JP H0228192 A JPH0228192 A JP H0228192A
Authority
JP
Japan
Prior art keywords
oligosaccharides
oligosaccharide
present
beta
lactose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP6005388A
Other languages
Japanese (ja)
Inventor
Fumio Nanjo
文雄 南条
Kazuo Sakai
和男 坂井
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yaizu Suisan Kagaku Kogyo Co Ltd
Original Assignee
Yaizu Suisan Kagaku Kogyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yaizu Suisan Kagaku Kogyo Co Ltd filed Critical Yaizu Suisan Kagaku Kogyo Co Ltd
Priority to JP6005388A priority Critical patent/JPH0228192A/en
Publication of JPH0228192A publication Critical patent/JPH0228192A/en
Pending legal-status Critical Current

Links

Landscapes

  • Saccharide Compounds (AREA)

Abstract

NEW MATERIAL:O-beta-2-Acetamide-2-deoxy-D-glucopyranosyl-(1 6)-O-beta-D- galactopyranosyl-(1 4)-D-glucose expressed by formula I (R1 is N- acetylglucosamine residue; R2 is H) and O-beta-D-galactopyranosyl-(1 4)-{O-beta-2- acetamide-2-deoxy-D-glucopyranosyl-(1 6)}-D-glucose. USE:Capable of utilizing in study of saccharides and as propagation accelerator of Bifidus bacterium. PREPARATION:The mixture of N-acetylchitooligosaccharide with lactic acid is reacted with beta-N-acetylhexosaminidase having sugar transfer ability.

Description

【発明の詳細な説明】 〔産業上の利用分野〕 本発明は、糖鎖の研究やビフィズス菌の増殖促進剤に利
用可能な新規オリゴ糖及V製造方法に関するものである
DETAILED DESCRIPTION OF THE INVENTION [Field of Industrial Application] The present invention relates to a method for producing a novel oligosaccharide and V which can be used for research on sugar chains and as a growth promoter for bifidobacteria.

〔従来の技術〕[Conventional technology]

最近、動物細胞表層に存在している糖タンパク質、糖ペ
プチドや糖脂質が、生体内でm要な生理学的機能を持っ
ているということが明らかになりつつある。例えば、m
胞表面のスフィンゴ糖脂質のいくつかは、血液型の特異
性に関与し、また臓器・組織の特異性にも関係している
Recently, it has become clear that glycoproteins, glycopeptides, and glycolipids present on the surface layer of animal cells have essential physiological functions in vivo. For example, m
Some of the glycosphingolipids on the cell surface are involved in blood type specificity, as well as organ/tissue specificity.

さらに、細胞や組織の発生・分化において細胞間認識部
位として重要な役割を演じている。ある峠のタンパク質
では、糖鎖構造の変化でその糖タンパク質の老朽化を感
知し、その代謝回転をルI整する機能が知られている。
Furthermore, it plays an important role as an intercellular recognition site in the development and differentiation of cells and tissues. It is known that certain glycoproteins have the ability to sense aging of the glycoprotein through changes in its sugar chain structure and adjust its turnover.

また、細胞表面にある糖ダ1は、〃ン化に伴ってその構
造が大きく変化するため、〃ン細胞と正常細胞を区別す
るための重要なマーカーとなる。このように、糖鎖のも
つ生理学的機能が明らかにされるにつれ、その研究はま
すます盛んになって米でいる。
In addition, since the structure of sugar 1 on the cell surface changes significantly with phosphorylation, it becomes an important marker for distinguishing between phosphorylated cells and normal cells. In this way, as the physiological functions of sugar chains are clarified, research on them is becoming more and more popular.

一方、ビフィズス菌は、人間の腸内に/F:をする有用
菌であり、それらが人間に及(rす生理学的及び栄養学
的な各種の有効性が報告されている。例えば、腸内腐敗
の抑制作用、ビタミンB及びB2の合成作用やタンパク
貿代謝に対する作用等が知られている。そのようなこと
から、ビフィズス菌の増殖を促進する物質について多く
の研究がなされている。最近では、腸内におけるビフィ
ズス菌の生育に重要な因子は、糖類て゛あるとの認識が
高まり、種々のオリゴ環をビフィズス菌の増殖促進因子
として利用する研究が嵜んになって来ている。
On the other hand, Bifidobacteria are useful bacteria that enter the human intestines, and their various physiological and nutritional effects on humans have been reported. It is known to inhibit putrefaction, synthesize vitamins B and B2, and affect protein trade metabolism.For this reason, much research has been conducted on substances that promote the growth of bifidobacteria.Recently, It has become increasingly recognized that sugars are important factors for the growth of bifidobacteria in the intestines, and research on the use of various oligo-rings as growth-promoting factors for bifidobacteria is increasing.

〔発明が解決しようとする課題〕[Problem to be solved by the invention]

本発明者らは、上述した様な現況に鑑み、オリゴ環につ
いて鋭意研究している過程で、新規オリゴ環を見出し、
分離・精製後、その構造を解析し本発明を完成するに至
った。
In view of the current situation as described above, the present inventors discovered a new oligo ring in the process of intensive research on oligo rings.
After separation and purification, the structure was analyzed and the present invention was completed.

以下に、本発明の詳細な説明する。The present invention will be explained in detail below.

〔発明の構成〕[Structure of the invention]

本発明における新規オリゴ環は、下記式(1)で示され
るO−β−2−アセトアミド−2−デオキシ−D−グル
コピラノシル−(1→6)−〇−β−D−ffラク)ビ
ラ/シル−(1→4)−D−グルコース及び、下記式(
2)で示されるO−β−D−77’ラクトピラノシルー
(1→4)−(〇−β−2−7セトアミドー2−デオキ
シ−D−グルコビラ7シルー(l→6)LD−グルコー
スである。
The novel oligo ring in the present invention is represented by the following formula (1): -(1→4)-D-glucose and the following formula (
2) O-β-D-77'lactopyranosyl(1→4)-(〇-β-2-7cetamido-2-deoxy-D-glucobyl-7silyl(l→6)LD-glucose) be.

また、これら2秤類の新規オリゴ環の製造方法は、N−
アセチルキトオリゴ糖と乳糖との渭、合物にβ−N−ア
セチルへキソサミニグーゼを作用させることを特徴とす
るものである。
In addition, the method for producing these two types of novel oligo rings is N-
It is characterized by allowing β-N-acetylhexosaminigase to act on a compound of acetyl chito-oligosaccharide and lactose.

N−アセチルグルコサミンと7(、糖の結合したオリゴ
環は、特開昭59−11190にみられるO−β−D−
ガラクトピラノシル−(1→4)−(0−β−2−アセ
ト7ミドー2−デオキシ−D−グルコピラノシル−(1
→2))−D−グルコースが知られているが、このオリ
ゴ環は N−7セチルグルコサミン残基が乳糖のグルコ
ース残基の2位の炭素原子と結合している。tχで、本
発明の2種類のオリゴ環とはhη造上異なる7 次に、本発明の構造について説明する。
The oligo ring with N-acetylglucosamine and 7(, sugar bonded is O-β-D-
Galactopyranosyl-(1→4)-(0-β-2-aceto7mido-2-deoxy-D-glucopyranosyl-(1
→2)) -D-glucose is known, and in this oligo ring, the N-7 cetylglucosamine residue is bonded to the carbon atom at the 2-position of the glucose residue of lactose. The two types of oligo rings of the present invention differ in terms of tχ and hη structure.7 Next, the structure of the present invention will be explained.

(イ)オリゴ環の畢今度 N−アセチルキトオリゴ糖、セロオリゴ環及びラミナリ
オリゴ糖を標準物質として、トーヨーパールHW−40
によってグルロ過ヲ行った結果、本発明に係わる2種類
のオリゴ環は、標準オリゴ環の3糖類両分に一致した溶
出位置を示したことがら3種類であると推定した。
(a) N-acetyl chito-oligosaccharide, cellooligo ring, and laminario-oligosaccharide were used as standard substances, and Toyo Pearl HW-40
As a result of the Glue filtration, the two types of oligo rings related to the present invention were estimated to be three types because they showed elution positions that corresponded to both trisaccharide components of the standard oligo ring.

(ロ)枯成糖 これらのオリゴ環にそれぞれβ−N−アセナルへキソサ
ミニグーゼを加え、40°Cで反応させ、そのときに生
成した糖を経(時変化をおって高速液体クロマトグラフ
ィーで分析した結果、生成糖とそのモル比は、8.24
及び48時間のいずれにおいてらN−7セチルグルフサ
ミン:ラクトース=1:1であることがら、これら2種
類のオリゴ環は両者とも1分子のN−アセチルグルコサ
ミンと1分子のラクトースからなる3糖類であることが
確認された。
(b) Dead sugars β-N-acenal hexosaminigase was added to each of these oligo rings and reacted at 40°C, and the sugars produced at that time were analyzed by high-performance liquid chromatography over time. As a result, the molar ratio of produced sugar to that is 8.24.
Since the ratio of N-7 cetylglucosamine to lactose is 1:1 at both the time and 48 hours, these two types of oligo rings are both trisaccharides consisting of one molecule of N-acetylglucosamine and one molecule of lactose. It was confirmed that there is.

(ハ)α結合、β結合の区別 これらのオリゴ糖は、β−N−アセチルヘキソサミニダ
ーゼによってN−7セチルグルフサミンとラクトース(
二分角IFされることから、β−結合であることが確認
された。また、表−Iに示した”C−N M Rの解析
結果もβ−結合であるということを裏付けている。
(c) Distinction between α-linkage and β-linkage These oligosaccharides are processed by β-N-acetylhexosaminidase into N-7 cetylglufusamine and lactose (
Since it was subjected to bisecting angle IF, it was confirmed that it was a β-bond. Further, the C-NMR analysis results shown in Table I also support that it is a β-bond.

(ニ)糖の結合様式 これら2種類のオリゴ糖についてそれぞれメチル化分析
を行った結果、式(1)のオリゴ糖では、3.4.6−
トリー〇−メチル−2(メチルアセトアミド)−D−グ
ルシトール、2.3.4−トリー〇−メチルーD−7ラ
クチトール、及び2.3.6〜トリー〇−メチル−D−
グルシトールの3種のフルジトールアセテートが検出さ
れたことから、N−7セチルグルコサミンがラクトース
のがラクトース残基の6位の炭素原子と結合しているこ
とが確認された。
(d) Sugar binding mode As a result of conducting methylation analysis on each of these two types of oligosaccharides, the oligosaccharide of formula (1) has 3.4.6-
tri〇-methyl-2(methylacetamide)-D-glucitol, 2.3.4-tri〇-methyl-D-7 lactitol, and 2.3.6-tri〇-methyl-D-
Since three types of fluditol acetate of glucitol were detected, it was confirmed that N-7 cetylglucosamine was bonded to the carbon atom at the 6-position of the lactose residue of lactose.

また、式(2)のオリゴ糖は、2.3、・116−チト
ラー○−メチルーD−ガラクチトール、3.4.6−ト
リー〇−メチル−2(メチルアセトアミド)−D−グル
シトール、及V2.3−ジー○−メチルーD−グルシト
ールの3種のアルク)−ルアセテートが検出されたこと
から、N−アセチルグルコサミンがラクトースのグルコ
ース残基の6位の炭素原子と結合していることが確認さ
れた。また、表−1に示した13C−pJMRL:r)
解析結果ら、上記結果をうまく藷、明するものであった
。。
Further, the oligosaccharides of formula (2) include 2.3, 116-thitra○-methyl-D-galactitol, 3.4.6-tri〇-methyl-2(methylacetamide)-D-glucitol, and V2 . Three types of alk)-acetates, 3-di○-methyl-D-glucitol, were detected, confirming that N-acetylglucosamine is bonded to the carbon atom at position 6 of the glucose residue of lactose. It was done. In addition, 13C-pJMRL:r) shown in Table-1
The analysis results clearly clarified the above results. .

以上述べた構造解析結果から、本発明に係わる2種類の
オリゴ糖は、それぞれ式(1)に示した〇−β−2−7
セトアミドー2−デオキシ−D−グルコピラノシル−(
1→6)−〇−β−D−77ラクトビラノシルー(1→
4)−D−グルコース及び、式(2)で示した0−β−
D4ラクトピラノシル−(1→4 )−+O−β−2−
7セトアミドー2−デオキシ−D−グルコビラノシルー
(1→6)iD−グルコースであると同定し得る。
From the structural analysis results described above, the two types of oligosaccharides related to the present invention are 〇-β-2-7 shown in formula (1), respectively.
Cetamido 2-deoxy-D-glucopyranosyl-(
1→6)-〇-β-D-77 Lactoviranosyl (1→
4) -D-glucose and 0-β- shown in formula (2)
D4 Lactopyranosyl-(1→4)-+O-β-2-
It can be identified as 7cetamido 2-deoxy-D-glucobylanosyl(1→6)iD-glucose.

次に、これらオリゴ糖の性質を示す。Next, the properties of these oligosaccharides will be shown.

(A)溶解性 これらオリゴ糖は、いずれら水に易溶であるが、アセト
ン・クロロホルム・ヘキサン等には不溶である。
(A) Solubility These oligosaccharides are easily soluble in water, but insoluble in acetone, chloroform, hexane, etc.

(B)呈色反応及び紫外吸収 7エ/−ルー硫酸法及びアルカリ性硝酸銀反応に対して
陽性を示し、210〜220 n mにN−7セチルグ
ルコサミン残基のア七ドアミド基に由来する紫外吸収を
示す。
(B) Color reaction and ultraviolet absorption 7E/-L sulfuric acid method and alkaline silver nitrate reaction showed positive results, and ultraviolet absorption at 210-220 nm derived from the 7-doamide group of the N-7 cetylglucosamine residue. shows.

(C)色調 これらオリゴ糖を乾燥粉末化したらのは、いずれも白色
を示r。
(C) Color: When these oligosaccharides are dried and powdered, they all exhibit white color.

(D>酸性、塩基性及び中性の区別 これらオリゴ糖は、いずれら中性を示す。(D> Distinction between acidic, basic and neutral All of these oligosaccharides are neutral.

以下、本発明に係わるオリゴ糖の製造方法について説明
する。
Hereinafter, the method for producing oligosaccharides according to the present invention will be explained.

本発明では、N−アセチルキトオリゴ糖と乳糖の’t?
?:合物を基質とし、β−N−アセチルへキソサミニグ
ーゼを作用させるが、ここで用いるN−アセチルキトオ
リゴ糖は、N−7セチルキトビオース、N−7セチルキ
トトリオース、N−7セチルキトテトラオース、N−7
セチルキトベンタオース、N−7セチルキトヘキサオー
スなどをそれぞれ単品で用いても、またこれらの混合物
、さらには単糖であるN−7セチルグルコサミンを含む
N−アセチルキトオリゴ糖混合物のいずれであっても良
い、また、ここで用いる基質は、N−アセチルキトオリ
ゴ糖を1〜30重量%及び乳糖を2〜40庫量%含む混
合物として使用し、 (11−1は、3〜8に!を持し
てβ−N−アセチルへキソサミニグーゼを10〜60℃
の温度で作用させる。このときに添加するβ−N−アセ
チルヘキソサミニダーゼの酵素量は、1〜200単位/
1fi1が良い。また、反応時間は、これら糖転移オリ
ゴ糖の収量が最も高くなる時間を適宜選択するのが好ま
しく、通常は3〜72時間である。また、本発明で用い
るβ−N−7セチルヘキンサミニグーゼは、N−アセチ
ルキトオリゴ糖を加水分解して中成するN−7セチルグ
ルコサミン残基を乳糖へ転移する作用を有するものであ
れば何れの起源のものであってもよい。例えば、微生物
由来のβ−N−7セチルへキソサミニダーゼが」二げら
れる。また、β−N−アセチルグルコサミニグーゼやβ
−N−アセナル〃ラクトサミニグーゼであっても、上述
の作用を示す酵素であればよい。
In the present invention, 't?' between N-acetylchitooligosaccharide and lactose is used.
? : The compound is used as a substrate and β-N-acetylhexosaminigase is applied. The N-acetyl chitooligosaccharides used here are N-7 cetylchitobiose, N-7 cetylchitotriose, N-7 cetyl chitotetraose, N-7
Cetylchitobentaose, N-7 cetylchitohexaose, etc. can be used alone, as a mixture of these, or as a mixture of N-acetylchitooligosaccharides containing the monosaccharide N-7 cetylglucosamine. Also, the substrate used here is a mixture containing 1 to 30% by weight of N-acetylchitooligosaccharide and 2 to 40% by weight of lactose, (11-1 is 3 to 8! β-N-acetylhexosaminigase at 10-60°C
Operate at a temperature of The amount of β-N-acetylhexosaminidase added at this time is 1 to 200 units/
1fi1 is good. Further, the reaction time is preferably selected appropriately, and is usually 3 to 72 hours, when the yield of these glycosyltransfer oligosaccharides is highest. Furthermore, the β-N-7 cetylhexamine saminigase used in the present invention has the effect of transferring N-7 cetylglucosamine residue, which is formed by hydrolyzing N-acetylchito-oligosaccharide, to lactose. It may be of any origin. For example, β-N-7 cetylhexosaminidase derived from microorganisms is mentioned. In addition, β-N-acetylglucosaminiguse and β
-N-acenal〃lactosaminigase may be used as long as it exhibits the above-mentioned action.

本発明では、上記の酵素反応によってN−7セチルグル
フサミンがラクトースに転移し、本発明に係わる2種類
のオリゴ糖を含む2R1合物が生成する。この反応液を
90°C以上で1〜2分間加熱することにより酵素反応
を1ヒめ、これを活性炭カラムに通液して反応液中のオ
リゴ糖のみを吸着させる。この吸着処理は、上記反応混
合物中の分解により生成したll糖を除去し、オリゴ糖
両分のみを得るために行なわれる。オリゴ糖を吸着させ
た活性炭カラムは、十分量の水で洗浄して単糖を完全に
除去し、続いて吸着したオリゴ糖を5〜40%エタノー
ル水溶液を用いて溶出する。このようにして得られる溶
出液には本発明の目的とするオリゴ糖のほか乳糖やN−
アセチルキトオリゴ糖なども含有しているので、本発明
ではさらに次のような工程を用いてvi製する。
In the present invention, N-7 cetylglufusamine is transferred to lactose by the above enzymatic reaction, and a 2R1 compound containing two types of oligosaccharides according to the present invention is produced. This reaction solution is heated at 90° C. or higher for 1 to 2 minutes to quench the enzyme reaction, and then passed through an activated carbon column to adsorb only the oligosaccharides in the reaction solution. This adsorption treatment is carried out in order to remove the 1/1 sugar produced by decomposition in the reaction mixture and obtain only the oligosaccharide components. The activated carbon column on which the oligosaccharides have been adsorbed is washed with a sufficient amount of water to completely remove the monosaccharides, and then the adsorbed oligosaccharides are eluted using a 5-40% ethanol aqueous solution. In addition to the oligosaccharides targeted by the present invention, the eluate thus obtained contains lactose and N-
Since it also contains acetyl chito-oligosaccharide, etc., in the present invention, vi is further produced using the following steps.

上記溶出液を減圧濃縮した後、これをゲルロ過削である
バイオデルP−2やバイオデルP−4カラムに)r1開
し水で溶出する6本発明のオリゴ糖は、フェノール−硫
酸法と210〜220nmに紫外吸収を示すことから、
これらの検出法でいずれら陽性になる両分を集める。こ
の溶出両分は、減圧濃!a後、トーヨーパールI−I 
W−40カラムに展開し、さらに精製を行う。上記の検
出法で陽性となる両分を集め、凍結乾燥し、本発明に係
わる2種類のオリゴ糖を含む混合物を+3る7これらの
オリゴ糖は、さらに分取用の高速液体クロマトグラフィ
ーを用いて分離、精製して本発明の2種類のオリゴ糖を
得ることができる。
After concentrating the above-mentioned eluate under reduced pressure, it was loaded onto a Gello overgrained Biodel P-2 or Biodel P-4 column) and eluted with water. Since it exhibits ultraviolet absorption at 220 nm,
Collect both samples that become positive using these detection methods. Both parts of this elution are concentrated under reduced pressure! After a, Toyo Pearl I-I
Develop on a W-40 column for further purification. Both fractions that are positive by the above detection method are collected and lyophilized to obtain a mixture containing the two types of oligosaccharides according to the present invention.7 These oligosaccharides are further processed using preparative high performance liquid chromatography. The two types of oligosaccharides of the present invention can be obtained by separation and purification.

本発明の方法において、特にビフィズス菌の増殖促進剤
として利用する場合には、式(1)及び式(2)のオリ
ゴ糖のはかN−アセチルキトオリゴ糖や乳糖を含んだ混
合物を粉末乾燥化して適用することも可能である。
In the method of the present invention, especially when used as a growth promoter for bifidobacteria, a mixture containing the oligosaccharides of formulas (1) and (2), N-acetylchito-oligosaccharide, and lactose is dried into powder. It is also possible to apply it by converting it into a

〔発明の効果〕〔Effect of the invention〕

本発明の新規オリゴ糖は、WI額の研究やビフィズス菌
の増殖促進剤として利用することのできるものである。
The novel oligosaccharide of the present invention can be used for research on WI amount and as a growth promoter for bifidobacteria.

〔実施例〕 以下に実施例をあげてさらに具体的に説明するが、かか
る説明が何ら限定されるものではないことは勿論のこと
である。
[Example] The present invention will be described in more detail below with reference to Examples, but it goes without saying that such explanation is not limited in any way.

N−7セチルキトビオ一ス10gと乳糖9gを50+a
M酢酸援衝液(p)(4,0) 40鴫1に溶解し、メ
カルディア・オリエンタリスI F’ 012806か
ら′A製したβ−N−アセチルへキソサミニダーゼ2 
、0004’lt位を加え、25°Cで20時間反応さ
せた。酵素反応を加熱して停止上させ、これに水60m
 lを加え希釈した。
10g of N-7 cetylchitobiots and 9g of lactose at 50+a
β-N-acetylhexosaminidase 2, prepared from Mecardia orientalis IF' 012806, dissolved in M acetic acid enriched solution (p) (4,0)
, 0004'lt was added and reacted at 25°C for 20 hours. Heat the enzyme reaction to stop it, and add 60 m of water to this.
1 was added to dilute the solution.

この溶1100mlをあらかじめ水で平衡化しrこ活性
炭−セライ) ll:1 )カラム(直径4cm、高さ
50cm)に通液して、オリゴ糖を吸着させた。
1,100 ml of this solution was equilibrated with water in advance and passed through an activated carbon-Celiac column (diameter 4 cm, height 50 cm) to adsorb oligosaccharides.

このカラムを2.517ツトルの水で洗浄した後、吸着
したオリゴ糖を20%エタノール水溶液2.5リツトル
で溶出した。得られた溶出液を減圧濃縮後、凍結乾燥し
て白色のオリゴ糖粉末8gを得た。
After washing this column with 2.517 liters of water, the adsorbed oligosaccharides were eluted with 2.5 liters of a 20% ethanol aqueous solution. The obtained eluate was concentrated under reduced pressure and then lyophilized to obtain 8 g of white oligosaccharide powder.

次に、このオリゴ糖(1,OR)を水10+olに溶解
後、あらかじめ水で平衡化したバイオデル P−2カラ
ム(直径5cII1.高さ184c鰺)に通し、デルロ
過ヲ行った。このとき、カラムは、ジャケットを用いて
55°Cに保った。オリゴ糖を水を用い、流速120+
i I / It”/で溶出し、溶出液を10m1づつ
分取した。
Next, this oligosaccharide (1, OR) was dissolved in 10+ ol of water, and then passed through a Biodel P-2 column (diameter: 5 cII 1, height: 184 c) that had been equilibrated with water, and subjected to Dell filtering. At this time, the column was maintained at 55°C using a jacket. Oligosaccharide using water, flow rate 120+
It was eluted with iI/It"/, and the eluate was collected in 10ml portions.

糖をフェノール−硫酸法と215n翔における吸光度の
測定によって検出し、目的とするオリゴ糖両分を集めた
。なお、この操作は、8回繰り返した。溶出液を減圧濃
!2!後、凍結乾燥して白色のオリゴ糖粉末3.6gを
得た。
Sugars were detected by the phenol-sulfuric acid method and absorbance measurement at 215n, and both target oligosaccharides were collected. Note that this operation was repeated eight times. Concentrate the eluate under reduced pressure! 2! Thereafter, the mixture was freeze-dried to obtain 3.6 g of white oligosaccharide powder.

オリゴ糖(0,9g)を水10u+lに溶解し、水で平
衡化したトーヨーバールHW−40Sカラム(10径5
cI@、高さ184c+a)に展開した。オリゴ糖を水
を用い、流速80m l 7時で溶出した。)容量層を
10 m lづつ分取し、上述の方法で糖を検出し、目
的とするオリゴ糖を集めた。なお、この操作は、4回繰
り返した。オリゴ糖両分を減圧濃縮後、凍結乾燥して白
色のオリゴ糖粉末1.4gを得た。
Oligosaccharides (0.9 g) were dissolved in 10 u+l of water, and a Toyovar HW-40S column (10 diameter 5
cI@, height 184c+a). Oligosaccharides were eluted with water at a flow rate of 80 ml at 7 hours. ) The volumetric layer was separated into 10 ml portions, sugars were detected by the method described above, and the desired oligosaccharides were collected. Note that this operation was repeated four times. Both oligosaccharide components were concentrated under reduced pressure and then lyophilized to obtain 1.4 g of white oligosaccharide powder.

さらに、このオリゴ糖画分に混在している式(1)と式
(2)のオリゴ糖を分離するため、下記の条件にて高速
液体クロマトグラフィーを行った。
Furthermore, in order to separate the oligosaccharides of formula (1) and formula (2) coexisting in this oligosaccharide fraction, high performance liquid chromatography was performed under the following conditions.

カラム:Y M C−P ack P A −43(2
0X 250+I1m)移動相:アセトニル:水=65
:35〜70:30流速:9.!lhl/分 検出:示差屈折計 サンプル%l:50−100+ng この分glt操作により式(1)のオリゴ糖0. zg
と式(2)のオリゴ糖0.2.を得た。
Column: YMC-Pack PA-43 (2
0X 250 + I1m) Mobile phase: acetonyl: water = 65
:35-70:30 flow rate:9. ! lhl/min detection: differential refractometer sample %l: 50-100+ng This minute glt operation resulted in 0.0% oligosaccharide of formula (1). zg
and oligosaccharide of formula (2) 0.2. I got it.

Claims (2)

【特許請求の範囲】[Claims] (1)下記の一般式 ▲数式、化学式、表等があります▼ で示され、R_1がN−アセチルグルコサミン残基、R
_2が水素であるO−β−2−アセトアミド−2−デオ
キシ−D−グルコピラノシル−(1→6)−O−β−D
−ガラクトピラノシル−(1→4)−D−グルコース及
び、R_1が水素、R_2がN−アセチルグルコサミン
残基であるO−β−D−ガクトピラノシル−(1→4)
−{O−β−2−アセトアミド−2−デオキシ−D−グ
ルコピラノシル−(1→6)}−D−グルコース。
(1) It is represented by the following general formula ▲ There are mathematical formulas, chemical formulas, tables, etc. ▼ where R_1 is an N-acetylglucosamine residue, R
O-β-2-acetamido-2-deoxy-D-glucopyranosyl-(1→6)-O-β-D where _2 is hydrogen
-galactopyranosyl-(1→4)-D-glucose and O-β-D-galactopyranosyl-(1→4) where R_1 is hydrogen and R_2 is an N-acetylglucosamine residue
-{O-β-2-acetamido-2-deoxy-D-glucopyranosyl-(1→6)}-D-glucose.
(2)N−アセチルキトオリゴ糖と乳糖との混合物に糖
転移能を有するβ−N−アセチルヘキソサミニダーゼを
作用させることを特徴とする特許請求の範囲第1項記載
のオリゴ糖の製造方法。
(2) Production of the oligosaccharide according to claim 1, characterized in that β-N-acetylhexosaminidase having transglycosylation ability is allowed to act on a mixture of N-acetylchitooligosaccharide and lactose. Method.
JP6005388A 1988-03-14 1988-03-14 Novel oligosaccaride and production thereof Pending JPH0228192A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP6005388A JPH0228192A (en) 1988-03-14 1988-03-14 Novel oligosaccaride and production thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6005388A JPH0228192A (en) 1988-03-14 1988-03-14 Novel oligosaccaride and production thereof

Publications (1)

Publication Number Publication Date
JPH0228192A true JPH0228192A (en) 1990-01-30

Family

ID=13130959

Family Applications (1)

Application Number Title Priority Date Filing Date
JP6005388A Pending JPH0228192A (en) 1988-03-14 1988-03-14 Novel oligosaccaride and production thereof

Country Status (1)

Country Link
JP (1) JPH0228192A (en)

Similar Documents

Publication Publication Date Title
EP1322673B1 (en) Polysaccharides with antithrombotic activity comprising at least a covalent bond with biotin or a biotin derivative
JPH06509703A (en) Enzymatic synthesis method of α-sialylated oligosaccharoid glycosides
WO2010023374A1 (en) Polysaccharides with antithrombotic activity, including a covalent bond and an amino chain
WO1999036443A1 (en) Synthetic polysaccharides, their method of production and pharmaceutical compositions containing same
EP1791872B1 (en) Biotinylated hexadecasaccharides, pharmaceutical compositions and use thereof
EP0126043A1 (en) Carbohydrate derivatives and compositions thereof for therapeutic or diagnostic use
JP3043888B2 (en) Colorectal cancer prophylactic agent containing glucomannan partial hydrolyzate as active ingredient
US4430322A (en) Modified glucans as anti-caries agent and method of use
US4340673A (en) Process of producing modified glucans as anti-caries agent
KR20080077913A (en) Method for preparing derivatives of glyco-compounds by using glycosyltransferases and the derivatives thereof
US6060597A (en) Cyclic oligosaccharide, and an agent containing the same for preventing or treating retroviral diseases
FI125039B (en) Purification procedure and preparation process for cellobiose
JPH0228192A (en) Novel oligosaccaride and production thereof
JPH0226638B2 (en)
JPH04309501A (en) Arabinoxylooligosaccharide
JPH0662852A (en) Fucoidanase
JPS603319B2 (en) amino sugar derivative
JP5331293B2 (en) Oligosaccharide or its derivatives expressing diversity
JP3816554B2 (en) Novel branched cyclodextrin and method for producing the same
JP4500008B2 (en) Novel disaccharide, composition containing the same, and method for producing the same
JPS6146479B2 (en)
JPH05230092A (en) N-acetylglucosamine-bonded oligosaccharide and its production
JP3048628B2 (en) Antitumor agent containing reduced hexa-N-acetyl-chitohexaose as active ingredient
JP3078377B2 (en) Method for producing mannosyl-transferred oligosaccharide
JP3691900B2 (en) Production method of carbohydrate